Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusio

Authors

  • Bethany W. Ibach, PharmD
  • Carol Loeber, MSN, APRN-CNP
  • Mohanad Shukry, MD
  • Tracy M. Hagemann, PharmD, FCCP, FPPAG
  • Donald Harrison, PhD, FAPhA
  • Peter N. Johnson, PharmD, BCPS

DOI:

https://doi.org/10.5055/jom.2015.0278

Keywords:

morphine, intrathecal, scoliosis, spinal fusion, pediatrics, child

Abstract

Objective: Intrathecal (IT) morphine improves pain control and decreases opioid requirements in children following thoracic and abdominal surgery. However, studies in children report variable durations of analgesia following IT morphine. The purpose of this study is to describe the duration of analgesia in children undergoing surgical correction of idiopathic scoliosis.

Design: Retrospective chart review.

Setting: Pediatric hospital within a tertiary care academic medical center.

Participants: Forty-four pediatric patients with idiopathic scoliosis who received IT morphine following posterior spinal fusion (PSF).

Main outcome measure(s): Mean opioid exposure 0-12 hours and 13-24 hours post-IT morphine.

Results: Mean opioid exposure was significantly increased during the 13-24-hour compared to the 0-12-hour time period (23.0 ± 12.5 mg parenteral morphine vs 15.9 ± 1.7 mg; p = 0.0006). The only factors significantly associated with morphine exposure during the 0-12-hour period included the median pain score (0-12 hours) (odds ratio [OR], 1.92; 95% confidence interval [CI], 0.033-3.80; p = 0.046) and total acetaminophen dose (OR, 0.003; 95% CI, 0.0008-0.005; p = 0.011).

Conclusions: These data indicate that patients experienced improved analgesia for at least 12 hours following IT morphine. Increased use of adjuvant analgesics such as acetaminophen may reduce opioid requirements following PSF procedures. More studies are needed to investigate the combination of adjuvants and IT morphine to reduce postoperative pain in this population.

Author Biographies

Bethany W. Ibach, PharmD

Assistant Professor, Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Abilene, Texas

Carol Loeber, MSN, APRN-CNP

Pediatric Pain Management Team, The Children’s Hospital at OU Medical Center, Oklahoma City, Oklahoma.

Mohanad Shukry, MD

Clinical Service Chief, Department of Anesthesiology, Children’s Hospital & Medical Center, Omaha, Nebraska.

Tracy M. Hagemann, PharmD, FCCP, FPPAG

Associate Dean, Nashville Campus, Professor, Department of Clinical Pharmacy, University of Tennessee College of Pharmacy, Nashville, Tennessee

Donald Harrison, PhD, FAPhA

Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma.

Peter N. Johnson, PharmD, BCPS

Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma

References

Kim HJ, Blanco JS, Widmann RF: Update on the management of idiopathic scoliosis. Curr Opin Pediatr. 2009; 21: 55-64.

Kepler CK, Meredith DS, Green DW, et al.: Long-term outcomes after posterior spine fusion for adolescent idiopathic scoliosis. Curr Opin Pediatr. 2012; 24: 68-75.

Gall O, Aubineau JV, Berniere J, et al.: Analgesic effect of low-dose intrathecal morphine after spinal fusion in children. Anesthesiology. 2001; 94(3): 447-452.

Krechel SW, Helikson MA, Kittle D, et al.: Intrathecal morphine (ITM) for postoperative pain control in children: A comparison with nalbuphine patient controlled analgesia (PCA). Paediatr Anesth. 1995; 5: 177-183.

Tripi PA, Poe-Kochert C, Potzman J, et al.: Intrathecal morphine for postoperative analgesia in patients with idiopathic scoliosis undergoing posterior spinal fusion. Spine. 2008; 33(20): 2248-2251.

Dalens B, Tanguy A: Intrathecal morphine for spinal fusion in children. Spine. 1988; 13(5): 494-498.

Milbrandt TA, Singhal M, Minter C, et al.: A comparison of three methods of pain control for posterior spinal fusions in adolescent idiopathic scoliosis. Spine. 2009; 34: 1499-1503.

Eschertzhuber S, Hohlrieder M, Keller C, et al.: Comparison of high- and low-dose intrathecal morphine for spinal fusion in children. Br J Anaesth. 2008; 100: 538-543.

Tobias JD: A review of intrathecal and epidural analgesia after surgery in children. Anesth Analg. 2004; 98: 956-965.

Blackman RG, Reynolds J, Shively J: Intrathecal morphine: Dosage and efficacy in younger patients for control of postoperative pain following spinal fusion. Orthopedics. 1991; 14(5): 555-557.

Dahlstrom B: Pharmacokinetics and pharmacodynamics of epidural and intrathecal morphine. Int Anesthesiol Clin. 1986; 24(2): 29-42.

Duramorph [package insert]. Eatontown, NJ: West-Ward Pharmaceuticals, August 2011.

Sadhasivam S, Krekels EHJ, Chidambaran V, et al.: Morphine clearance in children: Does race or genetics matter? J Opioid Manag. 2012; 4: 217-226.

Opioid Analgesics Comparison. Lexi-Comp Online, Pediatric and Neonatal Lexi-Drugs, Hudson, OH: Lexi-Comp, Inc., August 29, 2012.

Stata statistical software [computer program]. Version 13.1. College Station, TX: StataCorp LP, 2013.

Yeh YC, Reddy P: Clinical and economic evidence for intravenous acetaminophen. Pharmacotherapy. 2012; 32: 559-579.

Wong I, St John-Green C, Walker SM: Opioid sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children. Paediatr Anesth. 2013; 23: 475-495.

Macario A, Royal MA: A literature review of randomized clinical trials of intravenous acetaminophen (paracetamol) for acute postoperative pain. Pain Pract. 2011; 11: 290-296.

Published

07/01/2015

How to Cite

Ibach, PharmD, B. W., C. Loeber, MSN, APRN-CNP, M. Shukry, MD, T. M. Hagemann, PharmD, FCCP, FPPAG, D. Harrison, PhD, FAPhA, and P. N. Johnson, PharmD, BCPS. “Duration of Intrathecal Morphine Effect in Children With Idiopathic Scoliosis Undergoing Posterior Spinal Fusio”. Journal of Opioid Management, vol. 11, no. 4, July 2015, pp. 295-03, doi:10.5055/jom.2015.0278.